Summary
Overview
Work History
Education
Certification
Timeline
Others
Publications
Others
Publications
Hi, I’m

Aditya Kelkar

Pharma / Lifesciences Professional
Mumbai
Aditya Kelkar

Summary

Dynamic business leader with over 15 years of experience in the life sciences and pharmaceutical industry, including six years in consulting for global pharma and biotech companies. Proven expertise in people management, project execution, and strategic decision-making. In-depth expertise in scientific, clinical, regulatory, and commercial strategies, driving innovation and differentiation within the industry. Adept at devising insights and collaborating with senior leadership and C-suite executives to drive key strategic decisions and inform corporate and portfolio strategy

Overview

16
years of professional experience
2
Certificates

Work History

Sedulo Group - Life Science Division

Sr. Director Strategic Insights
2019 - Current (6 education.years_Label & 7 education.months_Label)

Job overview

  • Spearheaded the establishment of an insights function for the life science division by developing a strategic roadmap that positions the research team as a key thought partner for clients
  • Cultivated and maintained C-suite relationships with global pharma and biotech leaders, delivering in-depth therapy area analyses and competitive intelligence that directly informed multimillion-dollar strategic decisions
  • Successfully managed a high-value client portfolio, consistently delivering value on engagements that resulted in consistent renewals and building long-term partnerships
  • Strategically built and led an offshore team of CI analysts, resulting in enhanced research capabilities and a 30% reduction in operational costs
  • Pioneered innovative research frameworks that revolutionized competitor assessments, ensuring comprehensive and unbiased analysis for clients
  • Drove business development initiatives through expert project scoping, creation of compelling marketing content, and authorship of thought leadership articles
  • Led and mentored a cross-functional team of Client Engagement Managers, Insights Managers, and analysts, fostering professional growth and ensuring delivery of high-quality client deliverables
  • Optimized resource allocation by managing database subscriptions and negotiating multi-year contracts, achieving 20% reduction in annual subscription expenses

Cipla New Ventures (CNV)

Associate Director Competitive Intelligence
3 2014 - 2018

Job overview

  • Established Competitive Intelligence (CI) function and implemented robust CI processes to evaluate investment opportunities across multiple therapeutic areas
  • Performed strategic assessments of 50+ investment opportunities over 4 years, enabling Senior leadership to determine accurate valuations and make informed investment decisions
  • Developed comprehensive framework for competitive analysis, enhancing the division’s ability to identify and capitalize on market opportunities
  • Drove internal pipeline growth through active participation in product ideation sessions, focusing on addressing unmet needs in neurological and respiratory disorders
  • Leveraged insights from scientific conferences and Key Opinion Leader meetings to shape division’s strategy in emerging pharmacological advancements across multiple diseases

Vertex Pharmaceuticals

Manager Business Information
2012 - 2013 (1 education.year_Label)

Job overview

  • Delivered strategic competitive intelligence for multiple indications in autoimmune diseases and oncology, driving informed decision-making
  • Empowered business development and new product planning teams with comprehensive disease and market landscape analyses, facilitating successful market entry strategies
  • Spearheaded the creation of monthly and quarterly update reports, ensuring cross-functional teams at Vertex were consistently informed on competitor activities; recognized for exceptional collaboration across multiple high-impact projects

Amgen

Competitive Intelligence Analyst
1 2011 - 2012

Job overview

  • Worked closely with Amgen brand teams in Immunology and Supportive Oncology to conduct in-depth therapy area and landscape analyses
  • Proactively monitored market and competitor events, delivering timely and critical competitive intelligence updates with key takeaways and strategic implications for Amgen brands
  • Covered multiple medical conferences, providing timely competitor updates through well-designed, visual post-conference reports, ensuring stakeholders were informed with actionable insights

Office of Orphan Products Development (OOPD)

FDA Intern
2009 - 2009

Job overview

  • Conducted a comprehensive analysis of orphan drugs approved since the Orphan Drug Act, identifying key approval trends and their implications for future drug development.
  • Published findings in Nature Reviews Drug Discovery, a leading journal in the field, showcasing the importance and relevance of the research.
  • Contributed to the understanding of orphan drug approval trends, influencing policy and strategic decisions in the pharmaceutical industry.

Piramal Lifesciences

Research Associate - Diabetes Drug Discovery
2005 - 2007 (2 education.years_Label)

Job overview

  • Developed and optimized tissue culture techniques, cell maintenance protocols, and cryopreservation methods; designed novel assays to identify potential drugs for Type 2 diabetes
  • Coordinated and mentored undergraduate interns, enhancing their research skills and contributing to their professional growth

Education

University of Mumbai
Mumbai

Masters in Life Sciences, Biological Macromolecules from Biochemistry
06.2003 - 04.2005

Ramnarain Ruia College
Mumbai

Bachelors in Biochemistry
06.2000 - 04.2003

Keck Graduate Institute of Applied Life Sciences (KGI)
Claremont, CA

Masters of Bioscience (M.B.S.)
01.2008 - 04.2010

Certification

Strategic Management - Connected Strategy (The Wharton School)

Timeline

Strategic Management - Connected Strategy (The Wharton School)

03-2020

Sr. Director Strategic Insights

Sedulo Group - Life Science Division
2019 - Current (6 education.years_Label & 7 education.months_Label)

Manager Business Information

Vertex Pharmaceuticals
2012 - 2013 (1 education.year_Label)

US RAC (Regulatory Affairs Professionals Society, Washington DC)

04-2010

FDA Intern

Office of Orphan Products Development (OOPD)
2009 - 2009

Keck Graduate Institute of Applied Life Sciences (KGI)

Masters of Bioscience (M.B.S.)
01.2008 - 04.2010

Research Associate - Diabetes Drug Discovery

Piramal Lifesciences
2005 - 2007 (2 education.years_Label)

University of Mumbai

Masters in Life Sciences, Biological Macromolecules from Biochemistry
06.2003 - 04.2005

Ramnarain Ruia College

Bachelors in Biochemistry
06.2000 - 04.2003

Associate Director Competitive Intelligence

Cipla New Ventures (CNV)
3 2014 - 2018

Competitive Intelligence Analyst

Amgen
1 2011 - 2012

Others

Invited Speaker at National and International Competitive Intelligence Conferences 2017 -2019

Publications

  • Orphan products: an emerging trend in drug approvals. Nat Rev Drug Discov 2010 Jan; 9(1):84
  • Method for identifying compounds that act as insulin sensitizers (Patent; WO/2008/035309)
  • Discovery of P1736, a Novel Antidiabetic Compound That Improves Peripheral Insulin Sensitivity in Mice Models PLoS One. 2013; 8(10): e77946.

Others

Presented at multiple national and international Competitive Intelligence conferences, sharing insights and expertise with a global audience

Publications

  • Orphan products: an emerging trend in drug approvals. Nat Rev Drug Discov 2010 Jan; 9(1):84
  • Method for identifying compounds that act as insulin sensitizers (Patent; WO/2008/035309)
  • Discovery of P1736, a Novel Antidiabetic Compound That Improves Peripheral Insulin Sensitivity in Mice Models PLoS One. 2013; 8(10): e77946.
Aditya KelkarPharma / Lifesciences Professional